Organogenesis Holdings Inc. Class A Common Stock
$1.39
-$0.07 (-4.79%)
$1.38Day Range$1.47
Key Statistics
Market Cap
$187.86M
Shares Outstanding
128.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 29, 2016
Round Lot
100
Locale
US
Trading Data
Day Open
$1.45
Day High
$1.47
Day Low
$1.38
Volume
943.8K
VWAP
$1.41
Prev Close
$1.46
Transactions
--
Acc. Volume
--
About Organogenesis Holdings Inc. Class A Common Stock
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
PHARMACEUTICAL PREPARATIONSSIC 2834854 employees85 DAN ROAD, CANTON, MA, 02021781-575-0775IPO Nov 29, 2016US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001661181
- Composite FIGI
- BBG00FGGD295
- Share Class FIGI
- BBG00FGGD311
- Ticker Root
- ORGO
- SIC Code
- 2834
About Organogenesis Holdings Inc. Class A Common Stock (ORGO) Stock
Organogenesis Holdings Inc. Class A Common Stock (ORGO) closed the 2026-09-16 session at $1.39, down 4.79% versus the previous close (-0.07). The stock opened at $1.45 and traded between $1.38 and $1.47 during that session. Session trading volume was 944K shares. The volume-weighted average price (VWAP) is $1.41.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Organogenesis Holdings Inc. Class A Common Stock has a market capitalization of $187.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ORGO is listed on the XNAS exchange. The company employs approximately 854 people. Organogenesis Holdings Inc. Class A Common Stock is headquartered in CANTON, MA. The recorded listing date is 2016-11-29.
On this page you can find market ORGO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.